• Leucomycin (Kitasamycin): Mechanism & Assays

  2026-09-12

  Leucomycin, also called kitasamycin, is a multicomponent 16-membered macrolide antibiotic that inhibits bacterial protein synthesis through interaction with the 50S ribosomal subunit. Its research value includes translational inhibition studies, bacterial growth inhibition assays, antibacterial drug discovery, and macrolide resistance characterization.

• Trichostatin A (TSA): HDAC Mechanism and Cancer Research

  2026-09-11

  Trichostatin A (TSA) is a reversible HDAC inhibitor that increases histone acetylation and supports studies of epigenetic regulation in cancer. Its reported effects include breast cancer cell proliferation inhibition, cell cycle arrest, and differentiation, but assay-specific optimization is essential.

• 5-Azacytidine in Myeloma: ATR-Linked DNA Damage

  2026-09-11

  The reference study shows that 5-Azacytidine kills therapy-sensitive and therapy-resistant multiple myeloma cells through ATR-associated DNA damage responses and coordinated apoptotic signaling, rather than through demethylation alone. Its selective activity against malignant cells and synergistic interactions with doxorubicin and bortezomib provide a preclinical framework for combination-oriented multiple myeloma research.

• IWP-2 Workflow for Wnt Signaling Studies

  2026-09-10

  Use IWP-2 as a Porcupine-focused Wnt production inhibitor to separate ligand-supply effects from downstream pathway activity in cancer and epithelial models. This practical guide combines concentration planning, apoptosis assay design, high-content morphology, and troubleshooting with the morphological-profiling logic of a recent cardiomyopathy study.

• WST-8 Glucose Uptake Assay Kit Guide

  2026-09-10

  The WST-8 Glucose Uptake Assay Kit provides non-radioactive, colorimetric glucose uptake assay measurements through 2-deoxyglucose metabolism and 450 nm detection. Its stated 10–500 μM linear range supports quantitative cellular studies, while the Galectin-1–FIP200 findings provide a mechanistic context for hepatic insulin-resistance research.

• Carvedilol in β-Adrenergic Research Workflows

  2026-09-09

  Carvedilol is a versatile β-adrenergic receptor antagonist for separating receptor blockade, redox control, vascular remodeling, and tissue-regeneration phenotypes. This workflow-focused guide shows how to formulate it, select informative controls, and interpret emerging hematopoietic transplantation evidence without confusing nonselective β-blockade with β1-selective inhibition.

• Alisol A, Cholesterol, and Autophagy in VCI

  2026-09-09

  This Theranostics study identifies NAMPT as a central mediator of Alisol A neuroprotection in atherosclerosis-related vascular cognitive impairment. Using complementary behavioral, biochemical, imaging, lipidomic, and genetic approaches, the authors connect AMPK/NAMPT/SIRT1 signaling with cholesterol homeostasis, oxidative-stress control, and PINK1/PARKIN-dependent mitophagy.

• Imipenem Workflows for Antibacterial Research

  2026-09-08

  Build reproducible Imipenem workflows that connect susceptibility testing, PBP-centered mechanism studies, immune response modulation, and sepsis animal model design. The article emphasizes preparation, assay controls, resistance-aware interpretation, and practical troubleshooting rather than unsupported clinical extrapolation.

• Galectin-1–FIP200 Axis in Hepatic Steatosis

  2026-09-08

  The reference study identifies galectin-1 as an upstream suppressor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. Its combination of mouse gain-of-function experiments, proteomic analysis, interaction mapping, and mutational validation establishes the Gal-1–FIP200 axis as a mechanistic link between metabolic stress and defective autophagic flux.

• N6-Methyl-dATP for DNA Fidelity and AML Research

  2026-09-07

  N6-Methyl-dATP enables controlled tests of polymerase selectivity, methylation-dependent nucleotide recognition, and replication-associated genomic stability. This workflow connects rigorous biochemical controls with AML-focused assay design while clearly separating established findings from exploratory applications.

• Dimethyloxalylglycine (DMOG) Workflow Guide

  2026-09-07

  Dimethyloxalylglycine (DMOG) is a cell-permeable competitive PHD inhibitor used to stabilize HIF-1α and model hypoxia-related signaling under normoxic conditions. It is appropriate for controlled cellular and animal research, including hypoxia and inflammation studies, but is not intended for diagnostic, therapeutic, or medical use.

• RNA Clean and Concentrator Kit for NAFLD RNA

  2026-09-05

  Translate PINK1/Park2 mitophagy findings into cleaner, more reproducible RNA workflows for NAFLD research. This practical guide shows how to use a membrane-based RNA cleanup workflow for in vitro transcription products, assay controls, and RNA quality troubleshooting without overstating what purification alone can prove.

• CTOP: μ-Opioid Receptor Antagonist for Pain Research

  2026-09-04

  CTOP is a selective μ-opioid receptor antagonist peptide for opioid receptor binding studies and neuropharmacology opioid research. Its competitive MOR blockade provides a practical pharmacological control for testing opioid-dependent signaling, while recent mouse data define a brain-to-spinal circuit associated with mechanical hypersensitivity and tolerance.

• Trichostatin A (TSA) Assay Guide

  2026-09-04

  A practical, scenario-based guide to using Trichostatin A (TSA) in cell viability, proliferation, and cytotoxicity workflows. It explains how SKU A8183 can improve interpretability through controlled solvent handling, mechanistic controls, and evidence-based optimization.

• Resiquimod (R-848) in Thermal Ablation Workflows

  2026-09-03

  Resiquimod (R-848) provides a practical TLR7/8-driven bridge between local tumor ablation and innate immune activation. This workflow guide explains stock preparation, hydrogel-compatible assay design, thermal controls, and troubleshooting for chemo-immunomodulation studies.

8135 records 1/543 page Next 12345 下5页 Last page